ISIN | CH0294813149 |
---|---|
Valor Number | 29481314 |
Bloomberg Global ID | VOPIBIC SW |
Fund Name | Vontobel Fund (CH) - Pension Invest Balanced I |
Fund Provider |
VONTOBEL ASSET MANAGEMENT AG
Zürich, Switzerland Phone: +41 58 283 52 71 E-Mail: assetmanagement@vontobel.ch |
Fund Provider | VONTOBEL ASSET MANAGEMENT AG |
Representative in Switzerland |
Vontobel Fonds Services AG Zürich Phone: +41 58 283 74 77 |
Distributor(s) | Bank Vontobel AG, Ethos Services S.A., Genf |
Asset Class | Asset Allocation |
EFC Category | Multi-Asset Global Advanced Markets Balanced |
Distribution Policy | Accumulation |
Home Country | Switzerland |
Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | N/A |
Peculiarities |
Current Price * | 118.30 CHF | 03.10.2024 |
---|---|---|
Previous Price * | 118.54 CHF | 02.10.2024 |
52 Week High * | 118.96 CHF | 27.09.2024 |
52 Week Low * | 103.52 CHF | 23.10.2023 |
NAV * | 118.30 CHF | 03.10.2024 |
Issue Price * | 118.30 CHF | 03.10.2024 |
Redemption Price * | 118.30 CHF | 03.10.2024 |
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 47,347,416 | |
Unit/Share Assets *** | 1,188 | |
Trading Information SIX |
YTD Performance | +7.73% |
29.12.2023 - 03.10.2024
29.12.2023 03.10.2024 |
---|---|---|
1 month | +0.81% |
03.09.2024 - 03.10.2024
03.09.2024 03.10.2024 |
3 months | +1.73% |
03.07.2024 - 03.10.2024
03.07.2024 03.10.2024 |
6 months | +3.28% |
03.04.2024 - 03.10.2024
03.04.2024 03.10.2024 |
1 year | +12.27% |
03.10.2023 - 03.10.2024
03.10.2023 03.10.2024 |
2 years | +14.61% |
03.10.2022 - 03.10.2024
03.10.2022 03.10.2024 |
3 years | -1.25% |
04.10.2021 - 03.10.2024
04.10.2021 03.10.2024 |
5 years | +9.75% |
03.10.2019 - 03.10.2024
03.10.2019 03.10.2024 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Switzerland (Government Of) 0% | 24.88% | |
---|---|---|
JPM US Research Enh Eq ESG ETF USD Acc | 8.95% | |
UBS ETF BBG MSCI US Liq Cp Sust CHFh A-d | 8.94% | |
UBS(Lux)FS BlmbgMSCIGlbLqCpSsHCHFAAcc | 8.91% | |
JPM Eurozone Rsch EnhcdIdxEqESGETFEURacc | 7.03% | |
UBS(Lux)FS MSCI USA SRI USD Adis | 4.49% | |
Barings Global High Yield Bond B CHF Acc | 2.59% | |
Roche Holding AG | 2.36% | |
Novartis AG Registered Shares | 2.25% | |
Xtrackers Nikkei 225 ETF 1D | 2.02% | |
Last data update | 31.08.2024 |
TER | 0.77% |
---|---|
TER date | 29.02.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.65% |
Ongoing Charges *** | 0.71% |
SRRI ***
|
|
SRRI date *** | 30.09.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |
GMOs |